Emily E. Brown

1.1k total citations
20 papers, 887 citations indexed

About

Emily E. Brown is a scholar working on Molecular Biology, Ophthalmology and Oncology. According to data from OpenAlex, Emily E. Brown has authored 20 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Ophthalmology and 4 papers in Oncology. Recurrent topics in Emily E. Brown's work include Retinal Diseases and Treatments (6 papers), Retinal Development and Disorders (6 papers) and Retinoids in leukemia and cellular processes (3 papers). Emily E. Brown is often cited by papers focused on Retinal Diseases and Treatments (6 papers), Retinal Development and Disorders (6 papers) and Retinoids in leukemia and cellular processes (3 papers). Emily E. Brown collaborates with scholars based in United States, China and Germany. Emily E. Brown's co-authors include John D. Ash, Alfred S. Lewin, Cristhian J. Ildefonso, John G. Hoogerheide, Ferenc J. Kézdy, Roger A. Poorman, Linda Maggiora, Åke P. Elhammer, Adam A. Margolin and Shyemaa Shehata and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Emily E. Brown

20 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily E. Brown United States 13 639 283 132 115 96 20 887
А. Антонов Russia 11 838 1.3× 79 0.3× 80 0.6× 66 0.6× 19 0.2× 54 1.2k
Jian-Guo Ren United States 10 780 1.2× 62 0.2× 57 0.4× 99 0.9× 26 0.3× 13 1.1k
Quan Wu China 19 623 1.0× 291 1.0× 236 1.8× 54 0.5× 12 0.1× 32 1.0k
Burt T. Richards United States 11 412 0.6× 78 0.3× 59 0.4× 32 0.3× 44 0.5× 21 650
Edward Stuttfeld Switzerland 9 547 0.9× 24 0.1× 34 0.3× 64 0.6× 37 0.4× 11 743
Paul Rose United States 17 634 1.0× 31 0.1× 53 0.4× 205 1.8× 94 1.0× 21 1.1k
Barry J. Maurer United States 17 1.0k 1.6× 72 0.3× 17 0.1× 97 0.8× 69 0.7× 40 1.3k
Karim Rezaul United States 15 1.1k 1.7× 28 0.1× 50 0.4× 354 3.1× 17 0.2× 22 1.5k
Emanuel M. Schreiber United States 11 387 0.6× 41 0.1× 50 0.4× 25 0.2× 31 0.3× 12 621
Christian Beerli Switzerland 18 854 1.3× 11 0.0× 58 0.4× 226 2.0× 169 1.8× 31 1.2k

Countries citing papers authored by Emily E. Brown

Since Specialization
Citations

This map shows the geographic impact of Emily E. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily E. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily E. Brown more than expected).

Fields of papers citing papers by Emily E. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily E. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily E. Brown. The network helps show where Emily E. Brown may publish in the future.

Co-authorship network of co-authors of Emily E. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Emily E. Brown. A scholar is included among the top collaborators of Emily E. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily E. Brown. Emily E. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Emily E., et al.. (2023). Expression of NMNAT1 in the photoreceptors is sufficient to prevent NMNAT1-associated retinal degeneration. Molecular Therapy — Methods & Clinical Development. 29. 319–328. 2 indexed citations
2.
Brown, Emily E., et al.. (2023). Role of Nuclear NAD+ in Retinal Homeostasis. Advances in experimental medicine and biology. 1415. 235–239. 1 indexed citations
3.
Greenwald, Scott H., Emily E. Brown, Erin Hennessey, et al.. (2021). Mutant Nmnat1 leads to a retina-specific decrease of NAD+ accompanied by increased poly(ADP-ribose) in a mouse model of NMNAT1-associated retinal degeneration. Human Molecular Genetics. 30(8). 644–657. 13 indexed citations
4.
Brown, Emily E., et al.. (2021). Reduced nuclear NAD+ drives DNA damage and subsequent immune activation in the retina. Human Molecular Genetics. 31(9). 1370–1388. 8 indexed citations
5.
Xu, Lei, Emily E. Brown, Clayton P. Santiago, et al.. (2020). Retinal homeostasis and metformin-induced protection are not affected by retina-specific Pparδ knockout. Redox Biology. 37. 101700–101700. 5 indexed citations
6.
Greenwald, Scott H., Emily E. Brown, Erin Hennessey, et al.. (2020). Gene Therapy Preserves Retinal Structure and Function in a Mouse Model of NMNAT1-Associated Retinal Degeneration. Molecular Therapy — Methods & Clinical Development. 18. 582–594. 13 indexed citations
7.
Brown, Emily E., Alfred S. Lewin, & John D. Ash. (2019). AMPK May Play an Important Role in the Retinal Metabolic Ecosystem. Advances in experimental medicine and biology. 1185. 477–481. 5 indexed citations
8.
9.
Brown, Emily E., et al.. (2019). The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 60(5). 1470–1470. 79 indexed citations
10.
Ahmed, Chulbul M., Michael T. Massengill, Emily E. Brown, et al.. (2018). A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis. Experimental Eye Research. 177. 12–22. 30 indexed citations
11.
Ren, Xiang, Na Wang, Hui Qi, et al.. (2018). Up-Regulation Thioredoxin Inhibits Advanced Glycation End Products-Induced Neurodegeneration. Cellular Physiology and Biochemistry. 50(5). 1673–1686. 27 indexed citations
12.
Brown, Emily E., Alfred S. Lewin, & John D. Ash. (2018). Mitochondria: Potential Targets for Protection in Age-Related Macular Degeneration. Advances in experimental medicine and biology. 1074. 11–17. 56 indexed citations
13.
Brown, Emily E., John D. Ash, & Alfred S. Lewin. (2017). Deletion of Mitochondrial Antioxidant Enzyme Sod2 Induces Light-Dependent Retinal Degeneration with Aging. Investigative Ophthalmology & Visual Science. 58(8). 2294–2294. 1 indexed citations
14.
Ildefonso, Cristhian J., Emily E. Brown, Ryo Iwata, et al.. (2016). Targeting the Nrf2 Signaling Pathway in the Retina With a Gene-Delivered Secretable and Cell-Penetrating Peptide. Investigative Ophthalmology & Visual Science. 57(2). 372–372. 30 indexed citations
15.
Wei, Guo, Adam A. Margolin, Leila Haery, et al.. (2012). Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency. Cancer Cell. 21(4). 547–562. 140 indexed citations
16.
Landesman‐Milo, Dalit, Meir Goldsmith, Shani Leviatan Ben‐Arye, et al.. (2012). Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells. Cancer Letters. 334(2). 221–227. 55 indexed citations
17.
Corin, Karolina, Philipp Baaske, Deepali Ravel, et al.. (2011). Designer Lipid-Like Peptides: A Class of Detergents for Studying Functional Olfactory Receptors Using Commercial Cell-Free Systems. PLoS ONE. 6(11). e25067–e25067. 41 indexed citations
18.
Corin, Karolina, Philipp Baaske, Deepali Ravel, et al.. (2011). A Robust and Rapid Method of Producing Soluble, Stable, and Functional G-Protein Coupled Receptors. PLoS ONE. 6(10). e23036–e23036. 38 indexed citations
19.
Brown, Emily E., et al.. (1995). Prevention of acute graft-versus-host disease by treatment with a novel immunosuppressant. Cholera toxin B subunit.. The Journal of Immunology. 154(7). 3611–3617. 9 indexed citations
20.
Elhammer, Åke P., Roger A. Poorman, Emily E. Brown, et al.. (1993). The specificity of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase as inferred from a database of in vivo substrates and from the in vitro glycosylation of proteins and peptides. Journal of Biological Chemistry. 268(14). 10029–10038. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by А. Антонов Breakdown of academic impact, for papers by Jian-Guo Ren Breakdown of academic impact, for papers by Quan Wu Breakdown of academic impact, for papers by Burt T. Richards Breakdown of academic impact, for papers by Edward Stuttfeld Breakdown of academic impact, for papers by Paul Rose Breakdown of academic impact, for papers by Barry J. Maurer Breakdown of academic impact, for papers by Karim Rezaul Breakdown of academic impact, for papers by Emanuel M. Schreiber Breakdown of academic impact, for papers by Christian Beerli
Rankless by CCL
2026